Context-dependent regulation of ferroptosis sensitivity
- PMID: 35809566
- PMCID: PMC9481678
- DOI: 10.1016/j.chembiol.2022.06.004
Context-dependent regulation of ferroptosis sensitivity
Erratum in
-
Context-dependent regulation of ferroptosis sensitivity.Cell Chem Biol. 2022 Oct 20;29(10):1568. doi: 10.1016/j.chembiol.2022.08.008. Cell Chem Biol. 2022. PMID: 36270234 No abstract available.
Abstract
Ferroptosis is an important mediator of pathophysiological cell death and an emerging target for cancer therapy. Whether ferroptosis sensitivity is governed by a single regulatory mechanism is unclear. Here, based on the integration of 24 published chemical genetic screens combined with targeted follow-up experimentation, we find that the genetic regulation of ferroptosis sensitivity is highly variable and context-dependent. For example, the lipid metabolic gene acyl-coenzyme A (CoA) synthetase long chain family member 4 (ACSL4) appears far more essential for ferroptosis triggered by direct inhibition of the lipid hydroperoxidase glutathione peroxidase 4 (GPX4) than by cystine deprivation. Despite this, distinct pro-ferroptotic stimuli converge upon a common lethal effector mechanism: accumulation of lipid peroxides at the plasma membrane. These results indicate that distinct genetic mechanisms regulate ferroptosis sensitivity, with implications for the initiation and analysis of this process in vivo.
Keywords: ACSL4; PUFA; ROS; cancer; ether lipid; ferroptosis; iron.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests J.A.O. is a member of the scientific advisory board of Vicinitas Therapeutics. S.J.D. is a co-founder of Prothegen and a member of the scientific advisory boards for Ferro Therapeutics and Hillstream BioPharma. J.A.O. and S.J.D. hold patents related to ferroptosis.
Figures
Comment in
-
Ferroptosis execution: Is it all about ACSL4?Cell Chem Biol. 2022 Sep 15;29(9):1363-1365. doi: 10.1016/j.chembiol.2022.08.002. Cell Chem Biol. 2022. PMID: 36113403
